Special purpose acquisition company Arya Sciences Acquisition Corp. II took just 51 days to go from IPO to a $780 million business combination with Cerevel Therapeutics, in the second-fastest SPAC deal of the year. Stuart Cable, Jocelyn Arel and Dan Espinoza of Goodwin’s life sciences and SPAC teams are acting as legal counsel to Cerevel Therapeutics. Read the article in The Deal here.